bristane company briefing, page-5

Thanks, CGT.

For HRV Q1, I have got further questions: How long will the Vapendavir Phase III trials take? What is the possible earliest time for Vapendavir to hit the market given the availability of funding, successful FDA approval and other things all met?

If the patent life is until 2021 and the expected patent life in the market is only 5-6 years, that suggests that Vapendavir won't hit the market until about 2015-2-2016. The Phase III and FDA approaval will take more than 3 years?


I am a bit confused with this. Hope someone can clarify this issue.

Thanks.